69 growth-stage medtech investors in the US

Top 5 growth-stage medtech investors in the US, ranked by recent fund activity

Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (30: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (20; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (12) and completeness of the public record (8). Stage and regional focus are our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.

1. JSTAR Capital

   Type: VC firm · HQ: Austin, TX · Stages: Growth · Focus: Medtech, Healthtech, AI, Fintech · Latest activity: New fund, Aug 2026 · Fund size on file: $100M (SEC Form D, 2025)

   Latest fund filing dated Aug 2026; $100M fund on file (SEC Form D, 2025); 62% of its observed portfolio is medtech and medical devices; backs growth-stage; 8 named decision-makers on file.

2. Town Hall Ventures

   Type: VC firm · HQ: New York, NY · Stages: Growth · Focus: Medtech, Healthtech, Impact · Latest activity: New deal, Sep 2026 · Fund size on file: $400M (SEC Form D, 2025)

   Dated new deal in Sep 2026; $400M fund on file (SEC Form D, 2025); states medtech and medical devices as a focus; backs growth-stage; names the US as where it invests; 8 named decision-makers on file.

3. Echo Health Ventures

   Type: Corporate VC · HQ: Durham, NC · Stages: Growth · Focus: Medtech, Healthtech · Latest activity: Portfolio news, Sep 2026 · Private fund assets: $518M (SEC Form ADV)

   Portfolio news dated Sep 2026; $518M on file (SEC Form ADV); 77% of its observed portfolio is medtech and medical devices; backs growth-stage; 2 named decision-makers on file.

4. Longitude Venture Partners

   Type: VC firm · HQ: Menlo Park, CA · Stages: Growth · Focus: Medtech, Healthtech, Biotech · Latest activity: New deal, Jun 2026 · Fund size on file: $600M (SEC Form D, 2022)

   Dated new deal in Jun 2026; $600M fund on file (SEC Form D, 2022); states medtech and medical devices as a focus; backs growth-stage; names the US as where it invests; 8 named decision-makers on file.

5. MVM Partners LLP

   Type: VC firm · HQ: Boston, MA · Stages: Growth · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Jun 2026 · Private fund assets: $1.0B (SEC Form ADV)

   Portfolio news dated Jun 2026; $1.0B on file (SEC Form ADV); states medtech and medical devices as a focus; backs growth-stage; names the US as where it invests.

First 25 of 69 growth-stage medtech investors in the US

You are seeing 25 of 69. The full list adds 44 more investors and 383 named decision-makers.

How these 69 break down

Questions

Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices, growth-stage and the US. Guide: how many investors to pitch. Markdown version of this page.